# A Study of AL58805 in Patients With Advanced Tumors

> **NCT07179081** · PHASE1 · RECRUITING · sponsor: **Advenchen Laboratories Nanjing Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** AL58805

## Key facts

- **NCT ID:** NCT07179081
- **Lead sponsor:** Advenchen Laboratories Nanjing Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-20
- **Primary completion:** 2026-01-26
- **Final completion:** 2026-01-26
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07179081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07179081, "A Study of AL58805 in Patients With Advanced Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07179081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*